Golimumab

Category: Arthritis



Golimumab Overview

Golimumab (CNTO 148)[1] is a human monoclonal antibody which is used as an immunosuppressive drug and marketed under the brand name Simponi. Golimumab targets tumor necrosis factor alpha (TNF-alpha), a pro-inflammatory molecule[2] and hence is a TNF inhibitor. Profound reduction in C-reactive protein (CRP) levels, interleukin (IL)-6, intercellaular adhesion molecules (ICAM)-1, matrix metalloproteinase (MMP)-3, and vascular endothelial growth factor (VEGF) demon...

Read more Golimumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Golimumab

Recent Golimumab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Golimumab
  • Injection: 50mg, 50mg/4ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Golimumab: (1 result)

Sorted by National Drug Code
  • 57894-350 Simponi Aria 50 mg/4ml Intravenous Solution by Janssen Biotech, Inc.

Other drugs which contain Golimumab or a similar ingredient: (2 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 12 December 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA